Clinical Laserthermia Systems AB (publ) (CLS-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.161x

Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has a cash flow conversion efficiency ratio of -0.161x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.69 Million ≈ $-1.15 Million USD) by net assets (Skr66.48 Million ≈ $7.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Clinical Laserthermia Systems AB (publ) (CLS-B) liquidity interval to measure how many days the company can operate on defensive assets alone.

Clinical Laserthermia Systems AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Clinical Laserthermia Systems AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clinical Laserthermia Systems AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Interwood-Xylemporia A.T.E.N.E. AT:XYLEK	0.043x
Barramundi Group Ltd OL:BARRA	0.044x
Nimy Resources Ltd AU:NIM	-0.130x
Ebang International Holdings NASDAQ:EBON	-0.037x
AIR INDUSTRIES GR.DL-001 F:YH1	-0.031x
SRJ Technologies Group Plc AU:SRJ	-0.052x
Origin Agritech Ltd NASDAQ:SEED	0.216x
Lunai Bioworks Inc. NASDAQ:LNAI	0.079x

Annual Cash Flow Conversion Efficiency for Clinical Laserthermia Systems AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Clinical Laserthermia Systems AB (publ) market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr66.48 Million ≈ $7.15 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.499x	+41.89%
2024-12-31	Skr65.69 Million ≈ $7.07 Million	Skr-56.45 Million ≈ $-6.08 Million	-0.859x	+43.70%
2023-12-31	Skr43.53 Million ≈ $4.68 Million	Skr-66.45 Million ≈ $-7.15 Million	-1.527x	+83.01%
2022-12-31	Skr7.87 Million ≈ $846.40K	Skr-70.69 Million ≈ $-7.61 Million	-8.988x	-187.72%
2021-12-31	Skr21.18 Million ≈ $2.28 Million	Skr-66.17 Million ≈ $-7.12 Million	-3.124x	+21.47%
2020-12-31	Skr13.93 Million ≈ $1.50 Million	Skr-55.41 Million ≈ $-5.96 Million	-3.978x	+28.85%
2019-12-31	Skr7.00 Million ≈ $752.99K	Skr-39.12 Million ≈ $-4.21 Million	-5.591x	-619.15%
2018-12-31	Skr49.81 Million ≈ $5.36 Million	Skr-38.72 Million ≈ $-4.17 Million	-0.777x	-5.20%
2017-12-31	Skr33.00 Million ≈ $3.55 Million	Skr-24.39 Million ≈ $-2.62 Million	-0.739x	+35.74%
2016-12-31	Skr17.06 Million ≈ $1.84 Million	Skr-19.63 Million ≈ $-2.11 Million	-1.150x	-19.85%
2015-12-31	Skr19.46 Million ≈ $2.09 Million	Skr-18.68 Million ≈ $-2.01 Million	-0.960x	-92.50%
2014-12-31	Skr31.58 Million ≈ $3.40 Million	Skr-15.74 Million ≈ $-1.69 Million	-0.499x	+28.93%
2013-12-31	Skr26.09 Million ≈ $2.81 Million	Skr-18.30 Million ≈ $-1.97 Million	-0.702x	+0.45%
2012-12-31	Skr17.09 Million ≈ $1.84 Million	Skr-12.05 Million ≈ $-1.30 Million	-0.705x	-28.07%
2011-12-31	Skr10.83 Million ≈ $1.17 Million	Skr-5.96 Million ≈ $-641.36K	-0.550x	-15.89%
2010-12-31	Skr10.36 Million ≈ $1.11 Million	Skr-4.92 Million ≈ $-529.25K	-0.475x	-38.16%
2009-12-31	Skr6.63 Million ≈ $713.34K	Skr-2.28 Million ≈ $-245.16K	-0.344x	-1723.94%
2008-12-31	Skr3.68 Million ≈ $395.79K	Skr-69.30K ≈ $-7.46K	-0.019x	--

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices

Market Cap

$11.99 Million

Skr111.41 Million SEK

Market Cap Rank

#26593 Global

#575 in Sweden

Share Price

Skr3.58

Change (1 day)

+0.00%

52-Week Range

Skr2.83 - Skr11.82

All Time High

Skr1089.26